1-3 of 3
Cheryl Goldbeck, BS
Close
Sort by
Journal Articles

A Non-Internalizing Anti-CD40 Antibody, CHIR-12.12, Blocks CD40L-Induced Cytokine Production and Mediates Greater ADCC Than Rituximab in Primary CLL Cells.

Xia Tong, MSc, Sharon Lea Aukerman, PhD, Karen Lin, BS, Natasha Aziz, PhD, Cheryl Goldbeck, BS, Georgios V. Georgakis, MD, Anas Younes, MD, Wen-Kai Weng, MD, PhD, Susan O’Brien, MD, William Wierda, MD, PhD, Bahija Jallal, PhD, Mohammad Luqman, PhD
Journal: Blood
Blood (2005) 106 (11): 2964.
https://doi.org/10.1182/blood.V106.11.2964.2964
Published: 2005
Journal Articles

Human Antagonistic Anti-CD40 Antibody, CHIR-12.12, Inhibits CD40-Mediated Survival of Chronic Lymphocytic Leukemia B Cells Leading to Cellular Apoptosis.

Anu Cherukuri, PhD, Edward Kadel, BS, Sang H. Lee, PhD, Cheryl Goldbeck, BS, Carla Heise, PhD, Mohammad Luqman, PhD, Sharon L. Aukerman, PhD, Natasha Aziz, PhD, Susan O’Brien, MD, William G. Wierda, MD, PhD, Bahija Jallal, PhD
Journal: Blood
Blood (2005) 106 (11): 2965.
https://doi.org/10.1182/blood.V106.11.2965.2965
Published: 2005
Journal Articles

CHIR258: A Multitargeted Growth Factor Receptor Tyrosine Kinase (RTK) Inhibitor Induces Significant Apoptosis of Human FLT3 ITD Acute Myelogenous Leukemia Cells In Vitro and in Vivo.

Daniel L. Menezes, PhD, Marion Wiesmann, PhD, Sang Hoon Lee, PhD, Isabelle Lee, BS, Jing Peng, MS, Yan Tang, MD, Helen Ye, BS, Yoko Oei, BA, Cheryl Goldbeck, BS, Evelyn N. Garrett, MA, Carla Heise, PhD
Journal: Blood
Blood (2004) 104 (11): 1789.
https://doi.org/10.1182/blood.V104.11.1789.1789
Published: 2004